Gene · 310
Papers995
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 995
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction: Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7. | Sci Rep | 2026 | 42744935 | PubTator, text mining | PubMed |
| Composition and Function of Decellularized Human Lung Extracellular Matrix from Congenital Pulmonary Airway Malformation. | J Clin Med | 2026 | 42739747 | PubTator, text mining | PubMed |
| Retraction notice: AnnexinA7 down-regulation might suppress the proliferation and metastasis of human hepatocellular carcinoma cells via MAPK/ ERK pathway. | Cancer Biomark | 2026 | 42717846 | PubTator, text mining | PubMed |
| Osteoarthritis: molecular pathogenesis and potential therapeutic options. | Signal Transduct Target Ther | 2026 | 41781374 | PubTator, text mining | PubMed |
| Implantation awakens peri-implant osteogenic potential via Snx5-EGFR axis-mediated mechanical transduction. | Int J Oral Sci | 2026 | 41714616 | PubTator, text mining | PubMed |
| Hybrid endosomal coats contain different classes of sorting nexins. | EMBO J | 2026 | 41699388 | PubTator, text mining | PubMed |
| RNF168 promotes chronic colitis through ANXA7-mediated autophagy and NLRP3-driven pyroptosis. | Apoptosis | 2026 | 41518435 | PubTator, text mining | PubMed |
| Comprehensive Profiling of Annexins in Neuromuscular Disorders Reveals a Unique Signature in Dysferlinopathy. | Eur J Neurol | 2025 | 41327964 | PubTator, text mining | PubMed |
| Annexin A7 enhances TIA1 axonal trafficking to counteract pathological aggregation in neurons. | EMBO J | 2025 | 41188647 | PubTator, text mining | PubMed |
| SNX7 mediates inhibition of autophagy in prostate cancer via activation of CFLIP expression. | Discov Oncol | 2025 | 40883630 | PubTator, text mining | PubMed |
| Role of annexin A7 in the occurrence and progression of coronary atherosclerosis: a narrative review. | Cardiovasc Diagn Ther | 2025 | 40656785 | PubTator, text mining | PubMed |
| Revisiting the role of Annexins in membrane trafficking. | Cell Mol Life Sci | 2025 | 40506619 | PubTator, text mining | PubMed |
| Lipid Droplets Metabolism Mediated by ANXA7-PPARγ Signaling Axis Regulates Spinal Cord Injury Repair in Mice. | Adv Sci (Weinh) | 2025 | 39996504 | PubTator, text mining | PubMed |
| The RNA-Binding Properties of Annexins. | J Mol Biol | 2025 | 39755246 | PubTator, text mining | PubMed |
| Morphodynamical adaptation of the endolysosomal system to stress. | FEBS J | 2025 | 38706230 | PubTator, text mining | PubMed |
| Role of Annexin 7 (ANXA7) as a Tumor Suppressor and a Regulator of Drug Resistance in Thyroid Cancer. | Int J Mol Sci | 2024 | 39684934 | PubTator, text mining | PubMed |
| Correction: AnnexinA7 promotes epithelial-mesenchymal transition by interacting with Sorcin and contributes to aggressiveness in hepatocellular carcinoma. | Cell Death Dis | 2024 | 39614081 | PubTator, text mining | PubMed |
| Label-based comparative proteomics of oral mucosal tissue to understand progression of precancerous lesions to oral squamous cell carcinoma. | Biochem Biophys Rep | 2024 | 39483176 | PubTator, text mining | PubMed |
| UHRF1 knockdown induces cell cycle arrest and apoptosis in breast cancer cells through the ZBTB16/ANXA7/Cyclin B1 axis. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 39308302 | PubTator, text mining | PubMed |
| Matrix stiffness regulates the protein profile of extracellular vesicles of pancreatic cancer cell lines. | Proteomics | 2024 | 39279557 | PubTator, text mining | PubMed |
gene-search-2026-11-13-0.2.1
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/310/papers